Globus Medical Inc. (NYSE:GMED) had its target price dropped by equities researchers at Morgan Stanley from $28.00 to $25.00 in a research report issued on Thursday. The brokerage presently has an “equal weight” rating on the medical device company’s stock. Morgan Stanley’s target price points to a potential upside of 11.91% from the stock’s current […]
